4ZOM

RORgamma in complex with inverse agonist 4j.


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.27 Å
  • R-Value Free: 0.240 
  • R-Value Work: 0.200 
  • R-Value Observed: 0.202 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Discovery of novel pyrazole-containing benzamides as potent ROR gamma inverse agonists.

Wang, T.Banerjee, D.Bohnert, T.Chao, J.Enyedy, I.Fontenot, J.Guertin, K.Jones, H.Lin, E.Y.Marcotte, D.Talreja, T.Van Vloten, K.

(2015) Bioorg Med Chem Lett 25: 2985-2990

  • DOI: 10.1016/j.bmcl.2015.05.028
  • Primary Citation of Related Structures:  
    4ZOM

  • PubMed Abstract: 
  • The nuclear receptor RORγ plays a central role in controlling a pro-inflammatory gene expression program in several lymphocyte lineages including TH17 cells. RORγ-dependent inflammation has been implicated in the pathogenesis of several major autoimmune diseases and thus RORγ is an attractive target for therapeutic intervention in these diseases ...

    The nuclear receptor RORγ plays a central role in controlling a pro-inflammatory gene expression program in several lymphocyte lineages including TH17 cells. RORγ-dependent inflammation has been implicated in the pathogenesis of several major autoimmune diseases and thus RORγ is an attractive target for therapeutic intervention in these diseases. Starting from a lead biaryl compound 4a, replacement of the head phenyl moiety with a substituted aminopyrazole group resulted in a series with improved physical properties. Further SAR exploration led to analogues (e.g., 4j and 5m) as potent RORγ inverse agonists.


    Organizational Affiliation

    Chemistry and Molecular Therapeutics, Biogen, 12 Cambridge Center, Cambridge, MA 02142, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Nuclear receptor ROR-gamma ABCD225Homo sapiensMutation(s): 0 
Gene Names: RORCNR1F3RORGRZRG
Find proteins for P51449 (Homo sapiens)
Explore P51449 
Go to UniProtKB:  P51449
NIH Common Fund Data Resources
PHAROS:  P51449
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
4Q3
Query on 4Q3

Download Ideal Coordinates CCD File 
A, B, C, D
N-{4-[3-(acetylamino)-1-(propan-2-yl)-1H-pyrazol-5-yl]-2-[(1R,5S)-3-azabicyclo[3.1.0]hex-3-yl]phenyl}-2-chloro-6-fluoro-N-methylbenzamide
C27 H29 Cl F N5 O2
JGJWPIOGJPAGQE-KDURUIRLSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
4Q3IC50:  3   nM  Binding MOAD
4Q3IC50:  4.900000095367432   nM  BindingDB
4Q3EC50:  10   nM  BindingDB
4Q3EC50:  110   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.27 Å
  • R-Value Free: 0.240 
  • R-Value Work: 0.200 
  • R-Value Observed: 0.202 
  • Space Group: P 31
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 99.422α = 90
b = 99.422β = 90
c = 129.439γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
SCALAdata scaling
PDB_EXTRACTdata extraction
HKL-2000data reduction
MOLREPphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2015-05-06 
  • Released Date: 2015-06-17 
  • Deposition Author(s): Marcotte, D.J.

Revision History  (Full details and data files)

  • Version 1.0: 2015-06-17
    Type: Initial release
  • Version 1.1: 2015-06-24
    Changes: Data collection
  • Version 1.2: 2017-11-01
    Changes: Author supporting evidence, Database references, Derived calculations, Source and taxonomy